Adjuvant discovery and down-selection for vaccines against infectious and immune-mediated diseases
Active Definitive Contract Awarded Last action
- Contract number
- 75N93025C00020
- Awardee
-
Enepret Incorporated UEI P3KJFJJR58R4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,526
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20251 · Posted Jul 18, 2024
- Contract value 100% obligated
- $599,526.00 Current and potential, with all options
- Completion date 71% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, KY 40505, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $599,526 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $599,526 definitive contract to Enepret Incorporated for adjuvant discovery and down-selection for vaccines against infectious and immune-mediated diseases on June 1, 2025, under a firm fixed price structure.
The originating solicitation is the Small Business Innovation Research program, a total small business set-aside. The work encompasses adjuvant discovery and development of a more durable and universal adjuvanted influenza vaccine through synthetic biology approaches. Place of performance is Lexington, Kentucky. The contract is expected to complete on May 31, 2027.
Quick answers
Who was awarded contract 75N93025C00020?
75N93025C00020 was awarded to Enepret Incorporated by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2025.
How much is contract 75N93025C00020 worth?
The government has obligated $599,526 on 75N93025C00020.
Was contract 75N93025C00020 competed?
The extent of competition for 75N93025C00020 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award